Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2017: 100.00 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2019) [Effective from January 1, 2019]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2019)
[Effective from January 1, 2019]
For more details click here

ICV 2017: 100.00
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2017: 100.00
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2017: 100.00
NAAS RATING 2018: 5.38

Int.J.Curr.Microbiol.App.Sci.2019.8(5): 434-445
DOI: https://doi.org/10.20546/ijcmas.2019.805.051


Evaluation of Antimicrobial Activity of Cinnamaldehyde against Carbapenem-Resistant Acinetobacter baumannii Nosocomial Isolates
Ana Jessyca Alves Morais1, Izabelly Linhares Ponte Brito2, Xhaulla Maria Quariguasi Cunha Fonseca3, Vicente de Paulo Teixeira Pinto1,2 and Francisco Cesar Barroso Barbosa2*
1Postgraduate Program in Biotechnology
2Postgraduate Program in Health Sciences, Federal University of Ceará, Sobral, CE, Brazil
3Postgraduate Program in Medical Microbiology, Federal University of Ceará,
Fortaleza, CE, Brazil
*Corresponding author
Abstract:

The emergent and rapid spread of carbapenem-resistant A. baumannii isolates poses a severe threat to public health. Thus, the growing interest in new therapies based on natural products is the basic and primary source for the emergence of new antimicrobials. The aim of this study was to evaluate the antimicrobial activity of cinnamaldehyde against carbapenem-resistant A. baumannii nosocomial strains (n=47) isolated from patients in four teaching hospitals at Ceará, Brasil. Phenotypic identification and susceptibility to different antimicrobials were determined by VITEK®2, additionally gene blaOXA-51 was amplified by PCR on all presumptively identified as A. baumannii and the clinical characteristics were analyzed. The MIC of the cinnamaldehyde was performed according to microdilution methodology in standard 96-well polystyrene plates, according to the CLSI recommendations and MBC was determined. The MIC ranged from 125 to 500 μg/mL (Mean = 210.93 ± 58.55) and the MBC for most isolates was 250 μg/mL (Mean = 510.41 ± 230.39). Bloodstream was the most frequent isolation site, and most of the strains were isolated from Intensive Care Units. These data demonstrated a potent inhibitory and bactericidal effect of cinnamaldehyde against carbapenem-resistant A.baumannii nosocomial strains, suggesting the prospection of this compound for the development of a new antibacterial substance.


Keywords: Acinetobacter baumannii, Cinnamaldehyde, Multidrug-resistance, Nosocomial infection, Teaching hospital
Download this article as Download

How to cite this article:

Ana Jessyca Alves Morais, Izabelly Linhares Ponte Brito, Xhaulla Maria Quariguasi Cunha Fonseca, Vicente de Paulo Teixeira Pinto and Francisco Cesar Barroso Barbosa. 2019. Evaluation of Antimicrobial Activity of Cinnamaldehyde against Carbapenem-Resistant Acinetobacter baumannii Nosocomial Isolates.Int.J.Curr.Microbiol.App.Sci. 8(5): 434-445. doi: https://doi.org/10.20546/ijcmas.2019.805.051